At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,102 enrolled
Drug / intervention
low dose computed tomographydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer
In Brief
A clinical study evaluating low dose computed tomography for Lung Cancer. Completed, enrolled 1,102 participants.
Detailed Summary
Screening with the use of low-dose computed tomography (LDCT) reduces mortality from lung cancer. Relatives with family history of lung cancer are at increased risk of lung cancer compared to those without a family history in pooled analysis. A prospective trial using LDCT of lung to screen the relatives with family history of lung cancer is needed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
Countries--
CollaboratorsMinistry of Health and Welfare, Taiwan
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
Primary CompletionMar 2011
First PostedAug 2015
TodayJul 2026
First PostedAug 11, 2015
Enrollment StartAug 1, 2007
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 10.9 years ago
Interventions
low dose computed tomographydevice
Participants will receive 3 round of low dose computed tomography screening every year